Home › SEC Filings › Current Report (8-K)
Current Report (8-K)
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| LECO | 8-K | bullish | 6/10 | Lincoln Electric reported strong Q3 2026 results with net sales up 15.1% to $1.221 billion and adjusted EPS of $2.98, be | Oct 27, 2026 |
| BWIN | 8-K | mixed | 7/10 | Baldwin Insurance Group reported preliminary Q3 2026 results with total revenue of $480.3M (+31% YoY) and adjusted EBITD | Oct 27, 2026 |
| BX | 8-K | neutral | 3/10 | Blackstone announced its intention to offer senior notes through its indirect subsidiary Blackstone Reg Finance Co. L.L. | Oct 27, 2026 |
| THFF | 8-K | bullish | 6/10 | First Financial Corp reported Q3 2026 diluted EPS of $2.31, above the consensus estimate of $2.02, and net income of $27 | Oct 27, 2026 |
| GOVX | 8-K | bearish | 6/10 | GeoVax Labs entered into a $1 million unsecured revolving loan agreement with Bowery Consulting Group, with draws at the | Oct 27, 2026 |
| CBU | 8-K | neutral | 5/10 | CBU reported Q3 2026 GAAP EPS of $1.16, below the $1.19 consensus, and total revenue of $227.3M, essentially in line wit | Oct 27, 2026 |
| TTGT | 8-K | bearish | 5/10 | TechTarget reported underlying revenue growth of -1.6% for the nine-month period to September 30, 2026, reflecting conti | Oct 27, 2026 |
| RNA | 8-K | neutral | 3/10 | Atrium Therapeutics announced the first patient has been dosed in its Phase 1/2 Corventis clinical trial evaluating ATR | Oct 27, 2026 |
| LFWD | 8-K | neutral | 2/10 | Lifeward Ltd. appointed Ronen Tsimerman as Chief Financial Officer, effective November 1, 2026. The appointment is a rou | Oct 27, 2026 |
| AIAI | 8-K | neutral | 5/10 | AIAI Holdings entered into a Services Agreement with Messier 42 LLC (M42), a related party under common control, to form | Oct 27, 2026 |
| COCH | 8-K | bearish | 4/10 | Envoy Medical filed a certificate of amendment to effect a 1-for-10 reverse stock split of its Class A common stock, eff | Oct 27, 2026 |
| EARN | 8-K | bearish | 5/10 | Ellington Credit Co (EARN) entered into an equity distribution agreement with four placement agents to sell up to $125 m | Oct 27, 2026 |
| ITRI | 8-K | bullish | 6/10 | Itron reported Q3 2026 revenue of $599M (up 3% YoY) and non-GAAP diluted EPS of $1.94, beating the consensus estimate of | Oct 27, 2026 |
| MBOT | 8-K | neutral | 4/10 | Microbot Medical announced that ELMNT IR, a California-based outpatient interventional radiology practice, has signed an | Oct 27, 2026 |
| ESQ | 8-K | bullish | 6/10 | Esquire Financial Holdings reported Q3 2026 GAAP net income of $17.5M ($1.57 diluted EPS), up 34.7% from Q2 2026's $13.0 | Oct 27, 2026 |
| SCTH | 8-K | neutral | 5/10 | SecureTech Innovations entered into a comprehensive joint venture with Qstak Holding to form Qstak Market, LLC, which wi | Oct 27, 2026 |
| ARTV | 8-K | bearish | 6/10 | Artiva Biotherapeutics is discontinuing all development of its sole pipeline candidate AlloNK (AB-101) after updated lon | Oct 27, 2026 |
| PEW | 8-K | neutral | 5/10 | GrabAGun Digital Holdings Inc. (PEW) completed the acquisition of 100% of Camfour LLC, a wholesale distributor of firear | Oct 27, 2026 |
| ALT | 8-K | neutral | 3/10 | Altimmune appointed Peter Greenleaf and Alex Howarth to its board of directors, effective November 2, 2026, and increase | Oct 27, 2026 |
| CDT | 8-K | bearish | 6/10 | CDT entered an evaluation agreement with Manoira Corporation to assess its clinical-stage compounds AZD1656 and AZD5904 | Oct 27, 2026 |
| MRP | 8-K | bullish | 6/10 | Millrose Properties reported record Q3 2026 net income of $130.0M ($0.78 per share) and AFFO of $133.5M ($0.80 per share | Oct 27, 2026 |
| EEFT | 8-K | bearish | 6/10 | Euronet reported Q3 2026 revenue of $1.161B (up 1% YoY, 3% constant currency) and adjusted EPS of $3.55 (down 2% YoY), m | Oct 27, 2026 |
| BFH | 8-K | neutral | 4/10 | Bread Financial announced the launch of an underwritten public offering of depositary shares representing interests in i | Oct 27, 2026 |
| FCX | 8-K | bullish | 6/10 | Freeport-McMoRan reported Q3 2026 adjusted EPS of $0.88, above the $0.83 consensus, on revenue of $7.55B versus $7.40B c | Oct 27, 2026 |
| AIR | 8-K | bullish | 6/10 | AAR CORP. filed an 8-K furnishing an investor presentation detailing its agreement to acquire a 65% controlling interest | Oct 27, 2026 |
| ACLS | 8-K | neutral | 3/10 | Axcelis appointed Jeroen Delsman as EVP and CFO, effective November 12, 2026, succeeding interim CFO David Ryzhik who mo | Oct 27, 2026 |
| SXTP | 8-K | neutral | 5/10 | 60 Degrees Pharmaceuticals announced positive results from its expanded access study of tafenoquine combination regimens | Oct 27, 2026 |
| HUBB | 8-K | bullish | 6/10 | Hubbell reported Q3 2026 adjusted diluted EPS of $5.91, up 14% YoY, on net sales of $1.8725B (+25% YoY, organic +11%). T | Oct 27, 2026 |
| PCAR | 8-K | bullish | 6/10 | PACCAR reported Q3 2026 net income of $847.5M ($1.61 per diluted share) on revenues of $7.94B, compared to $590.0M ($1.1 | Oct 27, 2026 |
| CAC | 8-K | neutral | 4/10 | Camden National Corp reported Q3 2026 net income of $22.8M and diluted EPS of $1.34, up 8% and 7% YoY respectively. Net | Oct 27, 2026 |